 |
|
Elevated Plasma Pentraxin 3 and Its Association with Retinal Vein Occlusion
Kyung Soo Park, Ji Wan Kim, Jae Hwan An, Je Moon Woo
Korean J Ophthalmol. 2014;28(6):460-465. Published online 2014 Nov 19 DOI: https://doi.org/10.3341/kjo.2014.28.6.460
|
|
Citations to this article as recorded by
 Integrated Assessment of OCT, Multimodal Imaging, and Cytokine Markers for Predicting Treatment Responses in Retinal Vein Occlusion Associated Macular Edema: A Comparative Review of Anti-VEGF and Steroid Therapies
Marion R. Munk, Lala Ceklic, Richard Stillenmunkes, Varun Chaudhary, Nadia Waheed, Jay Chhablani, Marc D. de Smet, Anne Tillmann
Diagnostics.2024; 14(17): 1983. CrossRef Tumor Necrosis Factor Alpha-Induced Proteins in Malignant Tumors: Progress and Prospects Fang Guo, Yuan Yuan
OncoTargets and Therapy.2020; Volume 13: 3303. CrossRef Cytokines and Pathogenesis of Central Retinal Vein Occlusion
Hidetaka Noma, Kanako Yasuda, Masahiko Shimura
Journal of Clinical Medicine.2020; 9(11): 3457. CrossRef Increased Fibrinogen to Albumin Ratio in Ischemic Retinal Vein Occlusions
Hande Guclu, Sadık A. Ozal, Vuslat Pelitli Gurlu, Gülben Sayılan Özgün, Eray Özgün
European Journal of Ophthalmology.2017; 27(6): 735. CrossRef Intravitreal Dobesilate Injection for Macular Oedema Secondary to Branch Retinal Vein Occlusion
Cuevas Pedro
MOJ Clinical & Medical Case Reports.2016;[Epub] CrossRef The inflammatory protein Pentraxin 3 in cardiovascular disease
Francesco Fornai, Albino Carrizzo, Maurizio Forte, Mariateresa Ambrosio, Antonio Damato, Michela Ferrucci, Francesca Biagioni, Carla Busceti, Annibale A. Puca, Carmine Vecchione
Immunity & Ageing.2016;[Epub] CrossRef
|